Journal of Commercial Biotechnology

Journal of Commercial Biotechnology

I’ve recently joined the Journal of Commercial Biotechnology as managing editor. Drop me a line if you would like to make a submission.

The most recent issue, edited by Neil Henderson, has just been published:

Volume 13, Issue 3

Articles

When should you fire the founder? PDF
William Bains
Constructing a processual model of communication in new product development from a multiple case study of biotechnology SMEs PDF
Jennifer Frahm, David C Ireland, Damian Hine
A maturing industry: Strategic patenting trends, US and academic dominance, and the global biotechnology landscape PDF
Gareth Williams
Measuring performance of field-medical programmes: Medical science liaison metrics consensus PDF
Jane Chin
The commercialisation of bioinformatics and the threat of open-source software PDF
Joseph F Greco
Intellectual property issues in nanotechnology PDF
Lars Genieser, Michael Gollin
Fostering the process of adoption of personalised medicine: A matter of communication or a matter of cost? PDF
Pedro Reinares Lara, Emma Gutierrez de Mesa
Changing hopes and concerns about gene therapy in Japan PDF
Darryl Macer, Yoshihiro Okada, Makoto Nakagawa, MaryAnn Chen Ng, Masakazu Inaba

Legal and Regulatory Updates

Legal and regulatory update PDF
John Wilkinson

2 COMMENTS

Leave a Reply